Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Imaging infective endocarditis: Adherence to a diagnostic flowchart and direct comparison of imaging techniques
Published in: Journal of Nuclear Cardiology
Access to document
10.1007/s12350-018-1383-8
document
BACKGROUND: Multimodality imaging is recommended to diagnose infective endocarditis. Value of additional imaging to echocardiography in patients selected by a previously proposed flowchart has not been evaluated. METHODS: An observational single-center study was performed. Adult patients suspected of endocarditis/device infection were prospectively and consecutively enrolled from March 2016 to August 2017. Adherence to a diagnostic imaging-in-endocarditis-flowchart was evaluated in 176 patients. Imaging techniques were compared head-to-head in 46 patients receiving echocardiography (transthoracic plus transesophageal), multi-detector computed tomography angiography (MDCTA), and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET/CT). RESULTS: 69% of...
Anna Gomes, Peter Paul van Geel, Michiel Santing, Niek H J Prakken, Mathilde L Ruis, Sander van Assen, Riemer H J A Slart, Bhanu Sinha, Andor W J M Glaudemans
Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy
Published in: Cancers
Access to document
10.3390/cancers12040781
document
Molecular medicine has gained clinical relevance for the detection and staging of oncological diseases, to guide therapy decision making and for therapy follow-up due to the availability of new highly sensitive hybrid imaging camera systems and the development of new tailored radiopharmaceuticals that target specific molecules. The knowledge of the expression of different receptors on the primary tumor and on metastases is important for both therapeutic and prognostic purposes and several approaches are available aiming to achieve personalized medicine in different oncological diseases. In this review, we describe...
Alberto Signore, Chiara Lauri, Sveva Auletta, Michela Varani, Livia Onofrio, Andor W J M Glaudemans, Francesco Panzuto, Paolo Marchetti
European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Stent Graft Infections With the Endorsement of the European Association of Nuclear Medicine (EANM)
Published in: European Journal of Vascular and Endovascular Surgery
Access to document
10.1016/j.ejvs.2019.10.016
document
Nabil Chakfé, Holger Diener, Anne Lejay, Ojan Assadian, Xavier Berard, Jocelyne Caillon, Inge Fourneau, Andor W J M Glaudemans, Igor Koncar, Jes Lindholt, Germano Melissano, Ben R Saleem, Eric Senneville, Riemer H J A Slart, Zoltan Szeberin, Omke Teebken, Maarit Venermo, Frank Vermassen, Thomas R Wyss, Esvs Guidelines CommitteeGert J de Borst, Frederico Bastos Gonçalves, Stavros K Kakkos, Philippe Kolh, Riikka Tulamo, Melina Vega de Ceniga, Document Reviewers, Regula S von Allmen, Jos C van den Berg, E Sebastian Debus, Mark J W Koelemay, Jose P Linares-Palomino, Gregory L L Moneta, Jean-Baptiste Ricco, Anders Wanhainen
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-019-04481-7
document
PURPOSE: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after solid organ and hematopoietic stem cell transplantation, requiring a timely and accurate diagnosis. In this study, we evaluated the diagnostic performance of FDG-PET/CT in patients with suspected PTLD and examined if lactate dehydrogenase (LDH) levels, Epstein-Barr virus (EBV) load, or timing of FDG-PET/CT relate to detection performance of FDG-PET/CT. METHODS: This retrospective study included 91 consecutive patients with clinical suspicion of PTLD and a total of 97 FDG-PET/CT scans within an 8-year period. Pathology reports and a 2-year...
Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis
Published in: Mayo clinic proceedings
Access to document
10.1016/j.mayocp.2019.10.036
document
Dion Groothof, Hans L A Nienhuis, Johan Bijzet, Ewout J Houwerzijl, Maarten P van den Berg, Andor W J M Glaudemans, Riemer H J A Slart, Bouke P C Hazenberg